Management of acute liver failure as a key component of multiple organ dysfunction in patients with severe purulent peritonitis
https://doi.org/10.52888/0514-2515-2025-367-4-76-91
Abstract
Objective: to evaluate the effectiveness of planned relaparotomy with staged peritoneal lavage and small intestinal lavage using electrolyzed isotonic saline in the management of acute hepatic failure in patients with generalized purulent peritonitis.
Materials and methods: the study included 69 patients with generalized purulent peritonitis, divided into an intervention group (n = 35) and a control group (n = 34). After source control, the intervention group underwent planned relaparotomy with staged peritoneal lavage plus small intestinal lavage using electrochemically activated isotonic saline; controls received conventional peritoneal lavage with standard isotonic saline. The following parameters were evaluated: clinical status, characteristics and stage of acute hepatic failure, comorbidities, dynamics of hepatic blood flow (ultrasound with Doppler imaging), biochemical indices of liver and kidney function, inflammatory markers (interleukin-6, procalcitonin, D-dimer), hemostasis parameters, microbial contamination of the abdominal cavity, need for relaparotomy, incidence of recurrent peritonitis and septic complications, duration of mechanical ventilation, clinical recovery and mortality.
Results: use of planned relaparotomy with staged peritoneal lavage plus small intestinal lavage using electrolyzed isotonic saline was associated with faster restoration of portal venous flow and normalization of liver function. Portal vein blood flow velocity in the intervention group increased from 9.8 [8.7–10.9] to 19.2 [17.4–21.0] cm/s by day 15, whereas in the control group it increased from 9.6 [8.3–10.9] to 16.1 [14.5–17.7] cm/s. Total bilirubin decreased from 142 [130–154] to 54 [47–61] μmol/L in the intervention group and from 144 [131–157] to 78 [70–86] μmol/L in the control group. The time to bilirubin normalization was significantly shorter in the intervention group (6.8 [6.3–7.3] vs. 11.4 [10.6–12.2] days; p < 0.01), as was the time to INR normalization (7.2 [6.7–7.9] vs. 12.1 [11.2–13.0] days; p < 0.01). Levels of interleukin 6, procalcitonin and D-dimer decreased more markedly in the intervention group: by day 15, procalcitonin was 0.8 [0.7–0.9] vs. 1.5 [1.2–1.8] ng/mL, and D-dimer was 560 [499–621] vs. 840 [772–908] ng/mL. The total microbial load in the abdominal cavity decreased from 905 [815–995] to 13 [10–16] ×10³ CFU/mL in the intervention group and from 933 [838–1028] to 44 [38–50] ×10³ CFU/mL in the control group. The incidence of recurrent peritonitis was lower in the intervention group (8.6% vs. 26.5%; relative risk [RR] 0.32), as was the rate of septic complications (11.4% vs. 32.4%; RR 0.35; odds ratio [OR] 0.27; 95% confidence interval [CI] 0.08–0.96). Clinical recovery by hospital discharge was achieved in 85.7% of patients in the intervention group and in 61.8% in the control group (RR 1.39; OR 3.71; 95% CI 1.15–12.0). Mortality was 14.3% and 32.4%, respectively (RR 0.44).
Conclusions. Planned relaparotomy with staged peritoneal lavage combined with small intestinal lavage using using electrolyzed isotonic saline provides more effective management of acute hepatic failure in generalized purulent peritonitis, accelerates restoration of hepatic blood flow and normalization of biochemical and coagulation parameters, reduces the severity of systemic inflammation and microbial contamination of the abdominal cavity, and is associated with a lower incidence of septic complications and more than a twofold relative reduction in mortality.
About the Authors
Sh. Z. OtaevRussian Federation
Otaev Shukrullo Zuloliddinovich - postgraduate student of the Department of Surgical Diseases №1 named after Academician K.M. Kurbonov
Dushanbe
Sh. K. Nazarov
Russian Federation
Nazarov Shohin Kuvvatovich - Doctor of Medical Sciences, Head of the Department of Surgical Diseases №1 named after Academician K.M. Kurbonov
Dushanbe
B. K. Valiev
Russian Federation
Valiev Bobodzhon Komildzhonovich – PhD- doctoral student of the Department of Surgical Diseases No. 1 named after Academician K.M. Kurbonov
Dushanbe
A. M. Kholbegov
Russian Federation
Kholbegov Azimboy Mirzokhamdamovich - assistant of the Department of Surgical Diseases №1 named after
Academician K.M. Kurbonov
Dushanbe
S. G. Ali-Zade
Russian Federation
Ali-Zade Sukhrob Gaffarovich - Candidate of Medical Sciences, Associate Professor of the Department of Surgical Diseases No. 1 named after Academician K.M. Kurbonov
Dushanbe
F. P. Jalilov
Russian Federation
Jalilov Faridun Pirumshoevich - postgraduate student of the Department of Surgical Diseases №1 named after
Academician K.M. Kurbonov
Dushanbe
References
1. Kurbanov K.M. Purulent peritonitis: modern approaches to diagnosis and treatment. - Dushanbe: Irfon. 2018:324.
2. Gelfand B.R., Cherkasova I.G. Multiple organ failure syndrome. - M.: GEOTAR-Media.2016:352.
3. Pinchuk A.V., Boyko V.V., Chepkiy L.P. Acute peritonitis: diagnosis, treatment, prognosis. - Kyiv: Health. 2014:448.
4. Shalimov A.A., Saenko V.F. Surgery of abdominal organs. - Kyiv: Health. 2013:752
5. Lutsevich O.E. Acute peritonitis: modern methods of surgical correction. - M.: MEDpress-inform. 2019:264.
6. Kurygin A.A., Gostishchev V.K. Peritonitis. - M.: Medicine. 2009:384.
7. Malakhov I.S., Rudakov Yu.V. Acute liver failure in surgical infections. - St. Petersburg: Piter. 2020:288.
8. Revich B.A., Sindorskaya E.Yu. Hepatology: a guide for doctors. - M.: GEOTAR-Media; 2022:512.
9. Tarabrin O.A., Gladkikh F.V. Intensive care for multiple organ failure. - Odessa: ONMedU; 2019:340.
10. Clinical guidelines of the Ministry of Health of the Russian Federation. Acute peritonitis. - M.; 2022:56.
11. Sartelli M., Chichom-Mefire A., Labricciosa F.M. et al. WSES Guidelines for management of severe peritonitis. World Journal of Emergency Surgery. 2017;12:29. DOI: 10.1186/s13017-017-0141-4
12. Singer M., Deutschman C.S., Seymour C.W. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801– 810. DOI: 10.1001/jama.2016.0287
13. Ferreira A.M., Oliveira A., Bettencourt P. et al. Organ dysfunction and mortality in intra-abdominal sepsis. Critical Care Medicine. 2018;46(5):e419–e426. DOI: 10.1097/CCM.0000000000003032
14. Kumar V., Abbas A., Aster J. Robbins and Cotran. Pathologic Basis of Disease. 10th ed. Philadelphia: Elsevier; 2021.1408.
15. Bernal W., Wendon J. Acute liver failure. New England Journal of Medicine. 2013;369(26):2525–2534. DOI: 10.1056/NEJMra1208937
16. Strasberg S.M., Helton W.S. Acute calculous cholecystitis and peritonitis. Annals of Surgery. 2019;270(3):427–435. DOI: 10.1097/SLA.0000000000003466
17. Rahman T., Evans L. Multiple organ dysfunction syndrome. Current Opinion in Critical Care. 2021;27(1):1–9. DOI: 10.1097/ MCC.0000000000000795
18. Deitch E.A. Role of the gut in the development of sepsis and multiple organ failure. American Journal of Surgery. 2012;204(6):917–921. DOI: 10.1016/j.amjsurg.2012.08.009
19. Bihari D., Nichol A.D. Liver dysfunction in critical illness. Intensive Care Medicine. 2016;42:1579–1596. DOI: 10.1007/s00134-016-4397-3
20. Bakker J., Nijsten M.W., Jansen T.C. Clinical use of lactate monitoring in critically ill patients. Annals of Intensive Care. 2013;3:12. DOI: 10.1186/2110-5820-3-12
Review
For citations:
Otaev Sh.Z., Nazarov Sh.K., Valiev B.K., Kholbegov A.M., Ali-Zade S.G., Jalilov F.P. Management of acute liver failure as a key component of multiple organ dysfunction in patients with severe purulent peritonitis. Health care of Tajikistan. 2025;(4):76-91. (In Russ.) https://doi.org/10.52888/0514-2515-2025-367-4-76-91
JATS XML























